The State of C Difficile Care

December 7, 2021
Kenny Walter

Kenny Walter is an editor with HCPLive. Prior to joining MJH Life Sciences in 2019, he worked as a digital reporter covering nanotechnology, life sciences, material science and more with R&D Magazine. He graduated with a degree in journalism from Temple University in 2008 and began his career as a local reporter for a chain of weekly newspapers based on the Jersey shore. When not working, he enjoys going to the beach and enjoying the shore in the summer and watching North Carolina Tar Heel basketball in the winter.

Bincy Abraham, MD, led the State of Science program on C difficile infections.

Whether it is new treatments in development or new guidelines in managing clostridium difficile infections (CDI), there is plenty to discuss in this field.

That is why it is so important for experts to come together to discuss new research and different perspectives.

Last month, as part of HCPLive’s State of Science program, a group of 4 C difficile investigators and clinicians discussed several different portions of CDI care and research.

The program, called Institutional Perspectives in Infectious Diseases: Management of C. Difficile and led by Bincy Abraham, MD, MS, Houston Methodist, was held on Nov. 9.

Also joining the panel were Eamon Quigley, MD, Daniel Bushyhead, and Kerri L. Glassner, DO, all of Houston Methodist.